| Atrium Therapeutics, Inc. | RNA | Kathleen P. GallagherOfficer | Sep 18 | F | 11,632 | $8.95 | $104K |
| Atrium Therapeutics, Inc. | RNA | Kathleen P. GallagherOfficerDERIV | Apr 20 | A | 205,000 | $0.00 | —? |
| Atrium Therapeutics, Inc. | RNA | Kathleen P. GallagherOfficer | Apr 20 | A | 102,500 | $0.00 | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChiefDERIV | Feb 27 | D | 50,000 | — | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChiefDERIV | Feb 27 | D | 16,000 | — | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChiefDERIV | Feb 27 | D | 13,520 | — | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChiefDERIV | Feb 27 | D | 42,480 | — | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChiefDERIV | Feb 27 | D | 27,584 | — | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChiefDERIV | Feb 27 | D | 13,352 | — | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChiefDERIV | Feb 27 | D | 9,244 | — | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChiefDERIV | Feb 27 | D | 13,829 | — | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChiefDERIV | Feb 27 | D | 22,321 | — | — |
| Avidity Biosciences, Inc. | RNAM | Kathleen P. GallagherChief | Feb 27 | D | 80,303 | — | — |
| Avidity Biosciences, Inc. | RNA | Kathleen P. GallagherChief | Dec 17 | F | 8,030 | $71.87 | $577K |
| Avidity Biosciences, Inc. | RNA | Kathleen P. GallagherChief | Dec 17 | F | 33,336 | $71.87 | $2.4M |
| Avidity Biosciences, Inc. | RNA | Kathleen P. GallagherChief | Dec 17 | A | 72,000 | $0.00 | — |